ArticleQuantitative imaging in medicine and surgery2025
Quantitative assessment of patellofemoral osteoarthritis via the pressure band test: an innovative and objective test.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patellofemoral osteoarthritis (PFOA) is a prevalent subtype of knee osteoarthritis (OA), but due to its nonspecific symptoms and costliness in imaging, it is difficult to diagnose accurately, with the currently available methods lacking sensitivity and accessibility. This study aimed to develop and validate a novel, noninvasive, and cost-effective pressure band test (PBT) for the quantitative assessment of PFOA severity. Methods: This prospective cross-sectional study consecutively enrolled 1,059 participants between September 2022 and March 2024. Pain thresholds, defined as the lowest pressures needed to induce pain, were measured via a standardized PBT and validated against magnetic resonance imaging (MRI)-based Outerbridge scores, Kellgren and Lawrence (K&L) grading, and various patient-reported outcome measures (PROMs), including the numeric rating scale (NRS) for pain and the Lysholm Knee Scoring Scale. Statistical analyses included Pearson and Spearman correlation coefficients, receiver operating characteristic (ROC) curves, logistic regression models, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Nomograms were developed to facilitate individualized risk assessments, while subgroup and sensitivity analyses were applied to examine variations in NRS scores and other measurements. Results: ROC analyses demonstrated that models incorporating pressure measurements significantly outperformed those without them, achieving area under the curve values of 0.815 for the patella and 0.817 for the femur. Logistic regression confirmed that higher pressures correlated with a lower likelihood of PFOA. Notably, PBT's performance remained consistent across different NRS subgroups. Conclusions: PBT demonstrated significant potential as a valuable tool for the quantitative assessment of PFOA severity. This noninvasive and costeffective method may enhance diagnostic precision and be productively incorporated into routine clinical assessments. However, further research is necessary to validate these findings, clarify the long-term benefits, and evaluate the limitations of PBT in a diversity of clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.